deferiprone has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In summary, deferiprone induced declines in proliferative responses at a dosage that is within peak serum pharmacological concentrations." | 1.37 | Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects. ( Benedict, SH; Garcia, SL; LeVine, SM; Lynch, SG; Rues, L; Slusser, JG; Sweeney, ME, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sweeney, ME | 1 |
| Slusser, JG | 1 |
| Lynch, SG | 1 |
| Benedict, SH | 1 |
| Garcia, SL | 1 |
| Rues, L | 1 |
| LeVine, SM | 1 |
1 other study available for deferiprone and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
Topics: Adjuvants, Immunologic; Adult; Case-Control Studies; CD28 Antigens; CD4-Positive T-Lymphocytes; CD8- | 2011 |